Free Trial

MetLife (MET) 10K Form and Latest SEC Filings 2026

MetLife logo
$79.55 +1.47 (+1.88%)
As of 12:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest MetLife SEC Filings & Recent Activity

MetLife (NYSE:MET) has submitted 963+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in MetLife's financial statements. The most recent filing was a Form SCHEDULE 13D/A submitted on May 7, 2026.

Form 4
METLIFE INC Reports Ownership Change on May. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
MetLife Files Current Report on May. 6, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
MetLife Files Quarterly Report on May. 7, 2026

The 10-Q contains MetLife's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

MetLife SEC Filing History

Browse MetLife's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/07/2026 4:42 PM
BOARD OF DIRECTORS OF METLIFE INC (1111726) Filed by
MetLife (1099219) Subject
Form SCHEDULE 13D/A
05/07/2026 4:09 PM
MetLife (1099219) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 3:31 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2026 3:06 PM
MetLife (1099219) Issuer
O'Neill Adrienne Karen (2083481) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 10:43 AM
MetLife (1099219) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/29/2026 3:32 PM
MetLife (1099219) Filer
Form ARS
04/07/2026 5:05 AM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2026 3:04 PM
Johnson Jeh C. (1707516) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
MetLife (1099219) Issuer
WEINBERGER MARK A (1785997) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
GUTIERREZ CARLOS M (1185943) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
Glaser Daniel S (1420864) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
MCKENZIE DIANA (1754648) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
Hay Laura J (2013372) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
MetLife (1099219) Issuer
Mumenthaler Christian Stephane (2066326) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:04 PM
MetLife (1099219) Issuer
MORRISON DENISE M (1230166) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:05 PM
HUBBARD ROBERT GLENN (1283051) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:05 PM
Kennard William E (1198236) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:05 PM
MetLife (1099219) Issuer
Seitz Michelle (1836301) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:05 PM
Harris Carla A (1707351) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 9:48 AM
MetLife (1099219) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/20/2026 5:41 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2026 5:27 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2026 5:15 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2026 4:03 PM
MetLife (1099219) Subject
METROPOLITAN TOWER LIFE INSURANCE CO (728240) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2026 1:02 PM
Glaser Daniel S (1420864) Reporting
MetLife (1099219) Issuer
Form 3/A
03/19/2026 1:04 PM
Glaser Daniel S (1420864) Reporting
MetLife (1099219) Issuer
Form 4/A
03/05/2026 3:24 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2026 3:46 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 3:34 PM
Glaser Daniel S (1420864) Reporting
MetLife (1099219) Issuer
Form 3
Initial statement of beneficial ownership of securities  
02/26/2026 3:34 PM
MetLife (1099219) Issuer
Seitz Michelle (1836301) Reporting
Form 3
Initial statement of beneficial ownership of securities  
02/26/2026 3:35 PM
McCallion John D. (1709116) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:35 PM
Glaser Daniel S (1420864) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:35 PM
Khalaf Michel (1535491) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
MetLife (1099219) Issuer
Sibblies Shurawl (2030208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
MetLife (1099219) Issuer
O'Neill Adrienne Karen (2083481) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
MetLife (1099219) Issuer
PAPPAS BILL (1787586) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
Curtis Monica M (2031728) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
DEBEL MARLENE (1770295) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
MetLife (1099219) Issuer
Seitz Michelle (1836301) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:36 PM
MetLife (1099219) Issuer
TADROS RAMY (1714199) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 3:12 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
02/24/2026 3:46 PM
MetLife (1099219) Subject
Form FWP
02/24/2026 7:31 AM
MetLife (1099219) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
02/19/2026 4:34 PM
BOARD OF DIRECTORS OF METLIFE INC (1111726) Filed by
MetLife (1099219) Subject
Form SCHEDULE 13D/A
02/19/2026 3:34 PM
MetLife (1099219) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/04/2026 4:07 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 3:44 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2026 5:53 AM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2026 1:59 PM
MetLife (1099219) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
12/30/2025 5:03 AM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 5:18 AM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2025 3:24 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2025 3:21 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2025 3:13 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2025 3:17 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2025 3:27 PM
MetLife (1099219) Subject
METROPOLITAN TOWER LIFE INSURANCE CO (728240) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2025 3:37 PM
MetLife (1099219) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
11/06/2025 5:11 PM
BOARD OF DIRECTORS OF METLIFE INC (1111726) Filed by
MetLife (1099219) Subject
Form SCHEDULE 13D/A
11/05/2025 3:32 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2025 10:02 AM
MetLife (1099219) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
10/29/2025 3:29 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2025 3:15 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2025 7:01 AM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2025 5:40 PM
MetLife (1099219) Subject
METROPOLITAN TOWER LIFE INSURANCE CO (728240) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2025 5:47 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2025 5:52 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2025 5:35 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2025 3:33 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2025 3:02 PM
Johnson Jeh C. (1707516) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 3:02 PM
Kennard William E (1198236) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 3:02 PM
Hay Laura J (2013372) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 3:02 PM
MetLife (1099219) Issuer
Mumenthaler Christian Stephane (2066326) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 3:02 PM
Harris Carla A (1707351) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 3:02 PM
MCKENZIE DIANA (1754648) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 3:02 PM
HUBBARD ROBERT GLENN (1283051) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 3:07 PM
MetLife (1099219) Filer
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
07/28/2025 3:35 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2025 2:13 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025 1:11 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144/A
06/23/2025 3:08 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025 3:54 PM
MetLife (1099219) Subject
METROPOLITAN TOWER LIFE INSURANCE CO (728240) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025 3:43 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025 3:31 PM
Hay Laura J (2013372) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:31 PM
Harris Carla A (1707351) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:32 PM
GUTIERREZ CARLOS M (1185943) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:32 PM
Kennard William E (1198236) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:32 PM
MCKENZIE DIANA (1754648) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:32 PM
MetLife (1099219) Issuer
WEINBERGER MARK A (1785997) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:32 PM
MetLife (1099219) Issuer
Mumenthaler Christian Stephane (2066326) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:33 PM
MetLife (1099219) Issuer
MORRISON DENISE M (1230166) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:33 PM
Johnson Jeh C. (1707516) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Microscopic Footage Shows Immune Cells Attacking Cancer (Ad)

Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.tc pixel

Watch the footage and learn about the company's next catalyst
06/20/2025 3:33 PM
HUBBARD ROBERT GLENN (1283051) Reporting
MetLife (1099219) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025 3:34 PM
MetLife (1099219) Subject
METROPOLITAN LIFE INSURANCE CO/NY (728618) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025 3:17 PM
MetLife 401 (0) k
MetLife (1099219) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025 3:19 PM
MetLife (1099219) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

MetLife SEC Filings - Frequently Asked Questions

MetLife (MET) has submitted 963+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

MetLife's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on MetLife's financial statements page.

The most recent filing was a Form SCHEDULE 13D/A submitted on May 7, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:MET) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners